+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 18Years +
All Genders
ID02803294

Study of Transcatheter Aortic Valve Replacement for Treating Symptomatic Aortic Stenosis or Regurgitation in Chinese Patients

Led by Second Affiliated Hospital, School of Medicine, Zhejiang University · Updated on 2021-07-15

2000

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

This research aims to evaluate the safety and effectiveness of transcatheter aortic valve replacement in Chinese patients with symptomatic aortic stenosis or severe aortic regurgitation. The study is designed as a Phase 4 interventional trial conducted by the Second Affiliated Hospital, School of Medicine, Zhejiang University. Participants undergo physical exams and screening to confirm their condition and eligibility for the procedure. Those qualifying receive transcatheter aortic valve replacement, which is the only treatment approach assessed in this study. Throughout the study, patients are monitored for various health outcomes including death from any cause within one year, and other cardiovascular events such as stroke, myocardial infarction, and device success tracked over up to ten years. Patients must comply with follow-up visits at the investigational site to assess their condition and treatment effects over time.

CONDITIONS

Brief Title

Transcatheter Aortic Valve Replacement Single Center Registry in Chinese Population

Research Team

X

Xianbao Liu, MD

J

Jian-an Wang, MD,PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here